Board of Directors

The Gavin Glynn Foundation (CLBG) is a registered company in Ireland with our office based in Kilcoole, Co.Wicklow. CHY number is pending.

As a not-for-profit, charitable status company, The Gavin Glynn Foundation is governed by a Board of Directors none of whom take fees for their work or time.

At present, the board is comprised of:

• Jayne Glynn (Company Secretary)
• John Glynn (Director)
• Damian Gammell (Director)
• Sharon Walsh Gaynor (Marketing Director)
• Jane McDaid, (Marketing Director)
• Frank Giles MD (Medical Director)

John Glynn

John Glynn is Gavin’s father and the founder and Director of The Gavin Glynn Foundation.

John previous background was in Information Security and I.T, and while Gavin was in treatment he spent all his spare time reading medical articles and reaching out to other specialists from all corners of the globe to find the best treatment options for Gavin. John has built up a large network of medical specialists from all over the world. When Gavin passed last October John & Jayne knew that they must continue on and use their expertise and knowledge which they have gained while caring for Gavin to help other children and their families in Ireland and continue Gavin’s legacy.

Jayne Glynn

Jayne Glynn is Gavin’s mother, Co- Founder and Company Secretary for the Gavin Glynn Foundation.

Jayne resigned from her job as a school secretary when Gavin was first diagnosed back in October 2011 to become Gavin’s fulltime carer. Jayne looks after all of the fundraising and company files for The Gavin Glynn Foundation.

Francis J. Giles

Deputy Director Francis J. Giles, MB, MD, FRCPI, FRCPath is Professor of Medicine at Northwestern University Feinberg School of Medicine and Director of the Northwestern Medicine Developmental Therapeutics Institute.
A cancer specialist with more than two decades of experience, Dr. Giles has led the development of novel drugs, immunotherapies, and other highly targeted approaches, including cancer-directed viruses, monoclonal antibodies, and molecularly directed agents.
Among his many accolades, Dr. Giles was recently elected as a Fellow of the European Academy of Cancer Sciences. He earned his primary medical degree from the National University of Ireland, Galway (NUIG) and a Doctorate in medicine from NUIG in 2003. He is a Fellow of both the Royal College of Physicians of Ireland and the Royal College of Pathology (United Kingdom). Dr. Giles has particular interests in the mentoring of developmental therapeutics physician-scientists and in international collaborations across the bioscience spectrum. Prior to joining Northwestern, Dr. Giles was Director of the HRB Clinical Research Facility, Galway. He is a Professor of Cancer Therapeutics at both NUIG and Trinity College Dublin. Previously, Dr. Giles served as Deputy Director of the Cancer Therapy and Research Center at the University of Texas (UT) Health Science Center, San Antonio; Chief of the Division of Hematology and Medical Oncology; and Director of the Institute for Drug Development. His prior positions include serving as Professor in the Division of Cancer Medicine at the UT MD Anderson Cancer Center, Houston, and as a faculty member at the University of California, Los Angeles, and the University of North Carolina at Chapel Hill.
He is the founder and Chairman of both the International Oncology Study Group and the Developmental Therapeutics Consortium. He has authored more than 500 peer-reviewed articles on bioscience research in academic journals.

See more here

He has served as principal investigator on numerous national and international First in Human, Phase I, II, and III clinical studies of many novel agents, and holds numerous patents and technology licenses.
Dr. Giles has focused his clinical and research efforts on providing therapy for patients suffering from treatment-resistant or refractory cancer. He has pioneered the use of many agents that are now in regular use as targeted therapies for patients with cancer. Dr. Giles has particular interests in the mentoring of developmental therapeutics physician-scientists and in international collaborations across the bioscience spectrum.

Damian P. Gammell

Damian Paul Gammell is the Chief Executive Officer of Coca-Cola European Partners PLC. (CCEP).

 CCEP is the worlds largest Coca-Cola Bottler and employees over 25,000 across Western Europe.

Mr. Gammell served as the Chief Executive Officer of Anadolu Efes Biracilik ve Malt Sanayii Anonim Sirketi (alternate name: Anadolu Efes) at Anadolu Endüstri Holding A.S. from January 1, 2014 to October 2015 and Beverage Group President of Anadolu Group from January 1, 2014 to October 2015. Mr. Gammell served as Managing Director of Efes Soft Drink at Anadolu Efes Biracilik ve Malt Sanayii AS and served as its Group President of Efes Soft Drink since January 1, 2012. He served as Chief Executive Officer and Managing Director at Coca-Cola Icecek A.S. since January 1, 2012 until January 1, 2014. Prior to his appointment, Mr. Gammell served as President and Chief Executive Officer of Anadolu Beverage Group, one of the world’s largest beverage companies and owner of Coca-Cola Icecek. He joined Anadolu in 2010 from The Coca-Cola Company, where he served as head of the Companys operations in Germany since 2005 and in Russia from 2001 to 2004. He has over 20 years of experience in the Coca-Cola system, Mr. Gammell has also worked in Eastern Europe, Australia, Korea, Indonesia, Turkey, and Pakistan, among other locations. He served as the Chief Executive Officer at Coca-Cola Erfrischungsgetränke AG since 2005. He held a variety of senior roles across the fields of commercial and general management both in Europe and Australia. He served as Chief Executive Officer of the bottling business in Russia from 2001 to 2004. He led the German business through increasing both volume growth and profitability, consistently over the past 6 years. Mr. Gammell served as a Director at Coca-Cola Icecek A.S. until October 2015. He served as a Director of Anadolu Efes Biracilik ve Malt Sanayii Anonim Sirketi since February 4, 2014 until 2015.

He is involved in a number of global non-profit initiatives. He serves on the health care committee of the World Economic Forum.

In 2009, he was nominated as Young Global Leader (YGL) of the World Economic Forum. Mr. Gammell is a graduate of the College of Marketing, Dublin. He studied for his Master of Science in change management at Oxford University and HEC Paris and graduated with an Msc in Change Management. He has also completed programs at the Kennedy School of Government, Harvard University, and the Dublin Institute of Technology.

Jane McDaid

Jane McDaid is the founder of Thinkhouse, the youth communications agency.

With offices in Dublin and London, Thinkhouse helps global brands like Coca-Cola, Unilever, Three and Heineken Ireland connect with youth audiences around the world. With creativity and innovation at the centre of the agency’s DNA, under McDaid’s leadership Thinkhouse has hugely influenced the Irish and UK agency landscape with its fast evolving, innovative, creative and social-centric approach to communications strategies. Think house was listed as one of the World’s Leading Independent Agencies 2015 by global marketing publication, ‘Campaign’.

Jane is married to her husband and business partner David and her Three Children Heather, Fionnán and Limor and lives in Dublin.

www.thinkhouse.co.uk @thinkhouseUK

www.thinkhouse.ie @thinkhouseIE

Sharon Walsh

Sharon Walsh, Heineken Ireland Marketing Director.

With over 14 years marketing experience where she held senior marketing positions at Coca-Cola Ireland (Head of Marketing Sparkling Portfolio and Head of Media); Gilbey’s of Ireland and Diageo Ireland (Brand & Marketing Manager), Sharon Walsh joined Heineken Ireland in 2012 as Marketing Director. Walsh is responsible for the marketing of Heineken Ireland’s portfolio of brands to include Coors Light, Tiger Beer, Murphy’s Irish Stout, Paulaner, Beamish, Fosters, Desperados, Amstel, Moretti, Sol, Zyweic, Affligem and of course, Heineken itself. Since graduating from DCU with a Masters in Strategic International Marketing, Walsh has delivered some of Ireland’s most famous marketing campaigns and notched up many All Ireland Marketing Awards along the way.
Walsh is considered one of Ireland’s leading marketing experts. Her track record demonstrates that her strategic, single-minded approach to marketing unlocks real growth for brands under her guardianship.

www.heineken.ie